Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/12/1991 | EP0431038A1 Production of bluetongue virus non-structural proteins using a baculovirus expression vector |
06/12/1991 | EP0430972A1 Overexpression of phytochrome in transgenic plants |
06/12/1991 | CN1052142A Brain derived naurotrophic factor |
06/12/1991 | CN1052141A Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
06/12/1991 | CA2031763A1 Process for purification of a 69000 dalton antigentic protein from bordetella pertussis |
06/11/1991 | US5023328 Dna sequences; polypeptide; adipokinetic hormone |
06/11/1991 | US5023323 Method of somatotropin naturation |
06/11/1991 | US5023322 Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
06/11/1991 | US5023321 Molecular cloning and characterization of a further gene sequence coding for human relaxin |
06/11/1991 | US5023320 Adsorption using anionic exchange resin; gel filtration |
06/11/1991 | US5023242 Formed with organic acids; antibiotics; antimicrobial bandage, wound dressing |
06/11/1991 | US5023236 Factor VII/VIIA active site inhibitors |
06/11/1991 | US5023233 Fibrinogen receptor antagonists |
06/11/1991 | US5023181 Process for preparing a calcium-dependent oxygenase |
06/11/1991 | US5023180 Recombinant dna molecule |
06/11/1991 | US5023179 Promoter enhancer element for gene expression in plant roots |
06/11/1991 | US5023174 Recombinant Brucella abortus gene expressing immunogenic protein |
06/11/1991 | US5023077 Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
06/11/1991 | CA1284850C Carboxyalkyl peptide derivatives |
06/11/1991 | CA1284774C Dna fragments, expression vectors, hosts and process for production of apolipoprotein e |
06/09/1991 | WO1991009133A1 Recovery of bt endotoxin protein from lysed cell mixtures |
06/09/1991 | CA2070649A1 Recovery of bt endotoxin protein from lysed cell mixtures |
06/09/1991 | CA2031684A1 Pharmaceuticals |
06/09/1991 | CA2031468A1 Malaria vaccine |
06/08/1991 | WO1991009125A1 Proteins and nucleic acids |
06/08/1991 | WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins |
06/08/1991 | CA2069105A1 Proteins and nucleic acids |
06/08/1991 | CA2031644A1 Peptide antiviral agents |
06/08/1991 | CA2031450A1 Method of assaying or analyzing subtypes of human leukocyte interferons or their antibodies, and antibodies to be used therefor |
06/08/1991 | CA2031390A1 Process for producing des(64,65)-proinsulin |
06/06/1991 | WO1991007978A1 Synthetic calcitonin peptides |
06/06/1991 | DE4014260A1 New hirudin-poly:alkylene glycol conjugate(s) - used as anticoagulants for treatment and prophylaxis of myocardial infarct, arterial occlusion, venous thrombosis and pulmonary embolism |
06/06/1991 | DE3940067A1 New steroidogenesis-induced protein - used to treat conditions requiring stimulation of steroid production, without influencing cAMP cycle |
06/06/1991 | DE3939797A1 Neue vom neuropeptid y abgeleitete peptide New-derived neuropeptide y peptide |
06/06/1991 | DE3939470A1 Diagnosis and prevention of human parvovirus B19 infection - using synthetic penta- and higher peptide(s) and antibodies |
06/06/1991 | CA2069943A1 Synthetic calcitonin peptides |
06/06/1991 | CA2031369A1 Method for solubilization and naturation of somatotropins utilizing low urea concentration |
06/05/1991 | WO1991008313A1 Antisense oligonucleotide inhibition of papillomavirus |
06/05/1991 | WO1991007986A1 Method of treating septic shock |
06/05/1991 | EP0430930A1 Factor IX protein |
06/05/1991 | EP0430914A1 Diagnostic process |
06/05/1991 | EP0430645A2 Vaccines |
06/05/1991 | EP0430637A1 Fibrinolytic protein and production method thereof |
06/05/1991 | EP0430193A1 Monoclonal antibodies and their use |
06/05/1991 | EP0430121A1 Process for the purification of lipocortines |
06/05/1991 | EP0430066A1 DNA-sequence conferring resistance to the antibiotic thermorubin |
06/05/1991 | EP0430065A2 Barbiturate assay compositions and methods |
06/05/1991 | EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component |
06/05/1991 | EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity |
06/05/1991 | EP0429663A1 Human prourokinase-like polypeptides and their preparation methods |
06/05/1991 | EP0429628A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
06/05/1991 | EP0429611A1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
06/05/1991 | EP0429600A1 Saf polypeptide, gene, promoter and use for expression in streptomyces |
06/05/1991 | EP0429587A1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5. |
06/05/1991 | EP0429570A1 Osteoinductive compositions |
06/05/1991 | EP0429544A1 Synthetic, anti-complement protein and the gene encoding same |
06/05/1991 | EP0429538A1 Plant elongation factor, promoters, coding sequences and uses |
06/05/1991 | EP0429537A1 Atrial natriuretic peptide clearance inhibitors |
06/05/1991 | EP0429502A1 O-glycosylated igf-1 |
06/05/1991 | EP0429484A1 Porcine polyclonal and monoclonal antibodies |
06/05/1991 | EP0429483A1 Potyvirus coat protein genes and plants transformed therewith |
06/05/1991 | EP0429478A1 Expression cassette for plants. |
06/05/1991 | EP0429470A1 Antibody recognition of fragments from cytomegalovirus |
06/05/1991 | EP0406303A4 Assay for human immunodeficiency virus |
06/05/1991 | EP0394291A4 Means for diagnosing arc and aids |
06/05/1991 | CN1051937A Stem cell factor |
06/05/1991 | CN1051936A Drythropoietin isoforms |
06/05/1991 | CN1051934A Process for preparation of genelic vectors for nerve growth factor expression in eukaryotic cells |
06/05/1991 | CN1051933A Transformant containing ph081 promoter and use |
06/05/1991 | CN1051914A Peptides |
06/05/1991 | CA2070424A1 Method of treating septic shock |
06/04/1991 | US5021567 8-hydroxyquinoline chelating agents |
06/04/1991 | US5021560 Glycoprotein extract from proteolysis of molluscan hemocyanin |
06/04/1991 | US5021554 Process for protein particle size reduction using a fluid-energy mill |
06/04/1991 | US5021551 Method of enhancing peptide immunogenicity |
06/04/1991 | US5021549 Physiologically active substances, probestin and prostatin and production thereof |
06/04/1991 | US5021403 Antibiotic agents |
06/04/1991 | US5021349 Culture medium containing human albumin, process for the preparation of an injectable product from this medium, product obtained and its use, and composition obtained |
06/04/1991 | US5021347 DNA insert coding for a surface antigen |
06/04/1991 | US5021342 Vaccines |
06/04/1991 | US5021340 Genetic engineering |
06/04/1991 | US5021339 DNA sequence of glyceraldehyde-3-phosphate dehydrogenase promoter from yeast |
06/04/1991 | US5021337 Pressurization of sample, analyzing at selected infrared band |
06/04/1991 | US5021244 Immunizing a female with X or Y/X and Y-sam-protein |
06/04/1991 | US5021243 Process for the preparation of factor VIII:C-deficient plasma, and a deficient plasma obtained in this way |
06/04/1991 | CA1284625C Anti-human mesothelial cell monoclonal antibody |
06/03/1991 | CA2031246A1 Two-dimensionally crystallized macromolecular films |
06/02/1991 | WO1991008301A1 PROTEINS PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
06/02/1991 | WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding |
06/02/1991 | CA2070166A1 Proteins inhibiting the interaction between an immunoglobin fc fragment and its receptor, and their therapeutical use, especially in the treatment of hiv related ailments |
06/02/1991 | CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding |
05/30/1991 | WO1991008294A1 Novel vaccine |
05/30/1991 | WO1991008285A1 Production of recombinant human interleukin-1 inhibitor |
05/30/1991 | WO1991007979A1 Chimeric proteins |
05/30/1991 | WO1991007510A1 A method of detecting htlv-i antibodies in human body fluids |
05/30/1991 | WO1991007509A1 Localization and characterization of the wilms's tumor gene |
05/30/1991 | WO1991007502A1 Methods and reagents to detect and characterize norwalk and related viruses |
05/30/1991 | WO1991007499A1 The scl gene, and the encoded hematopoietic factor |
05/30/1991 | WO1991007497A1 Expression of heterologous proteins using eucaryotic cells |
05/30/1991 | WO1991007496A1 Cloning and expression of genes encoding for polypeptides comprised of one or more repeating amino acid sequences |